OM1’s Dr. Richard Gliklich presents on leveraging the AAO-HFN Reg-ent Registry for research at the FDA-MDEpiNet conference “Cochlear Implant Innovation, Research and Advancement (CIRCA). View Agenda >>
Taylor & Francis Online Published: January 20, 2022 Read the Full Manuscript >> Objective To compare healthcare resource use (HCRU) in patients undergoing sinus surgery with or without steroid-eluting sinus implants. Methods A retrospective, observational cohort study using real-world evidence data (OM1, Inc, Boston, MA, USA) was conducted on adult patients with chronic rhinosinusitis (CRS)[…]
Thu, Feb 17, 2022 11:00 AM – 12:00 PM EST Register >> Exacerbated by the pandemic, Mental Health disorder prevalence continues to rise. The growing unmet need is driving a renewed interest in research and development programs. Yet, the complexities of these neurological conditions continue to present challenges. Deep clinical data can offer insights into[…]
Tue, Jan 25, 2022 12:30 PM – 1:30 PM EST Presenter: Rich Gliklich, CEO, OM1 Register >> Real-World Data (RWD) and Artificial Intelligence (AI) applications are rapidly growing in importance in R&D for Chronic and Immune-mediated Diseases. Join us as we explore: Data Networks The ‘Unstructured’ Medical Record Hybrid Data Collection Data Linkage Artificial Intelligence[…]
December 20, 2021 – Orphanet Journal of Rare Diseases Read the Full Article >> Background Fabry disease (FD) is a rare genetic disorder characterized by glycosphingolipid accumulation and progressive damage across multiple organ systems. Due to its heterogeneous presentation, the condition is likely significantly underdiagnosed. Several approaches, including provider education efforts and newborn screening, have[…]
